{"createdAt":"8/2/2020, 2:34:17 PM","timestamp":1596393257890,"Company ID number":"622","DMX_ISSUER_NAME":"Dong-E-E-Jiao Co., Ltd.","DMX_ISSUER_ID":"IID000000002125917","Country of Classification":"CHINA","name":"Dong-E-E-Jiao Co Ltd ","code":"000423","stock_exchange":"Shenzhen Stock Exchange","people":[{"id":"东阿阿胶股份有限公司_韩跃伟","group":"board","name":"韩跃伟","title":"董事长,董事","isMale":true,"age":"52","degree":"硕士","salary":"0.00","stockAmount":"-","description":"韩跃伟先生:男,1968年3月出生,持有清华大学土木工程系建筑管理学士学位和清华大学建筑经济与管理硕士学位,曾任深圳市建筑工务署市政处处长、华润集团深圳区域工委书记、华润置地有限公司副总裁、华润医疗控股有限公司行政总裁、华润健康集团有限公司党委副书记、总经理等职务。现任华润医药控股有限公司党委书记、华润医药集团有限公司执行董事、首席执行官。","lastUpdated":"2019-12-11"},{"id":"东阿阿胶股份有限公司_高登锋","group":"board","name":"高登锋","title":"董事","isMale":true,"age":"47","degree":"硕士","salary":"126.7万","stockAmount":"-","description":"高登锋,男,1973年1月出生,硕士研究生学历,工商管理硕士学位。1995年9月在东阿阿胶参加工作,历任东阿阿胶销售代表、销售主管、办事处经理、市场部经理/总监、西南西北区总监、高端产品事业部总监、江苏销售分公司总经理、苏皖销售分公司总经理、人力资源部总监、保健品公司总经理、电子商务公司总经理、助理总裁等职务。现任东阿阿胶股份有限公司党委委员、副总裁。","lastUpdated":"2020-05-27"},{"id":"东阿阿胶股份有限公司_吴怀峰","group":"board","name":"吴怀峰","title":"董事","isMale":true,"age":"58","degree":"硕士","salary":"153.2万","stockAmount":"3.991万","description":"吴怀峰(曾用名:吴怀锋):男,1962年出生,会计师,1979年进入东阿阿胶厂工作,曾任财务科副科长、财务处长、山东东阿阿胶股份有限公司公司副总经理;参加过清华大学MBA培训,曾获山东省\"富民兴鲁\"劳动奖章,《新财富》第四届至第七届金牌董秘.现任山东东阿阿胶股份有限公司董事、副总经理董事会秘书。","lastUpdated":"2018-08-30"},{"id":"东阿阿胶股份有限公司_吴峻","group":"board","name":"吴峻","title":"董事","isMale":true,"age":"58","degree":"硕士","salary":"0.00","stockAmount":"-","description":"吴峻:男,1962年8月出生,持有天津大学机械工程类硕士学位,美国旧金山大学工商管理硕士学位。曾任华润机械五矿(集团)有限公司董事、总经理,华润集团企业开发部副总经理,华润投资开发有限公司董事、副总经理,华润集团审计部副总经理。现任华润医药集团高级副总裁,同时担任华润三九医药股份有限公司董事、华润双鹤药业股份有限公司监事、东阿阿胶股份有限公司董事。","lastUpdated":"2018-06-27"},{"id":"东阿阿胶股份有限公司_翁菁雯","group":"board","name":"翁菁雯","title":"董事","isMale":false,"age":"44","degree":"硕士","salary":"0.00","stockAmount":"-","description":"翁菁雯女士:女,1976年1月出生,持有浙江大学经济学学士及中国香港科技大学工商管理硕士学位,曾任普华永道中天会计师事务所审计和商业咨询部高级审计师、华润燃气(集团)有限公司内审部总经理、审计总监、战略总监、华润(集团)有限公司战略管理部副总监等职务。现任华润医药集团有限公司党委委员、副总裁、首席财务官。","lastUpdated":"2019-12-04"},{"id":"东阿阿胶股份有限公司_王立志","group":"board","name":"王立志","title":"董事","isMale":true,"age":"56","degree":"本科","salary":"0.00","stockAmount":"-","description":"王立志:男,1964年8月出生,大学学历,历任聊城市经委生产调度室科员、副科级秘书、副主任、科长;山东鑫亚工业股份有限公司副董事长、副总经理;鲁西化工集团公司、昌润投资发展公司监事会主席。现任聊城市东元资产经营有限公司董事长、总经理,现任东阿阿胶股份有限公司董事。","lastUpdated":"2018-06-27"},{"id":"东阿阿胶股份有限公司_张炜","group":"board","name":"张炜","title":"独立董事","isMale":true,"age":"49","degree":"博士","salary":"12.00万","stockAmount":"-","description":"张炜:男,1971年6月出生,1998年获北京协和医学院临床医学博士学位,2005年获哈佛大学博士学位(医疗政策)。擅长企业战略和商业模式创新研究,曾执教于中欧国际工商学院,创建中欧医疗管理与政策研究中心。现任职于北京大学光华管理学院,北京大学政府管理学院兼职教授;兼任中国医师协会经济评价中心副主任。现任东阿阿胶股份有限公司独立董事。","lastUpdated":"2018-06-27"},{"id":"东阿阿胶股份有限公司_张元兴","group":"board","name":"张元兴","title":"独立董事","isMale":true,"age":"66","degree":"博士","salary":"12.00万","stockAmount":"-","description":"张元兴:男,1954年8月出生,1984年获华东化工学院化学工程专业硕士学位,博士生导师,1998年享受国务院政府特殊津贴。曾任国家863计划海洋技术领域专家组副组长,华东理工大学生物工程学院院长。现受聘为生物反应器工程国家重点实验室副主任,国家海洋食品工程技术研究中心专家指导委员会副主任,福建省海洋功能食品工程技术研究中心技术委员会主任,山东省水产动物免疫制剂工程研究中心专家委员会主任,福建省海洋生物资源开发利用协同创新中心学术委员会副主任等。","lastUpdated":"2018-06-27"},{"id":"东阿阿胶股份有限公司_路清","group":"board","name":"路清","title":"独立董事","isMale":true,"age":"54","degree":"硕士","salary":"12.00万","stockAmount":"-","description":"路清先生:1966年7月出生,中国国籍,无境外永久居留权,研究生学历,注册会计师,高级会计师职称。1999年9月至2001年9月,担任山东中立信会计师事务所副所长;2001年9月至2003年10月,担任天一会计师事务所合伙人;2003年10月至2009年9月,担任中和正信会计师事务所合伙人;2009年9月至今,担任信永中和会计师事务所合伙人;现任东阿阿胶股份有限公司的独立董事、威海市商业银行股份有限公司独立董事。2016年12月至今,担任青岛威奥轨道股份有限公司独立董事。","lastUpdated":"2018-06-27"},{"id":"东阿阿胶股份有限公司_陶然","group":"supervisoryCommittee","name":"陶然","title":"监事会主席","isMale":true,"age":"55","degree":"硕士","salary":"0.00","stockAmount":"-","description":"陶然:男,1965年10月出生,持有上海交通大学工学学士、北京航空航天大学经济学硕士学位。曾任中国华润总公司(现为中国华润有限公司)进口一部副科长,华润纺织集团有限公司投资部高级经理、战略部总经理、公司副总经理,华润医药集团有限公司战略发展部高级总监、战略发展部总经理。现任华润医药集团有限公司助理总裁。","lastUpdated":"2019-08-22"},{"id":"东阿阿胶股份有限公司_唐娜","group":"supervisoryCommittee","name":"唐娜","title":"监事","isMale":false,"age":"44","degree":"硕士","salary":"0.00","stockAmount":"-","description":"唐娜:女,1976年12月出生,持有中国政法大学法学学士学位,曾于中国人民大学城市经济学专业研究生班学习。曾任北京市共和律师事务所合伙人、华润医药商业法律事务总监。现任华润医药集团有限公司总法律顾问。","lastUpdated":"2019-06-19"},{"id":"东阿阿胶股份有限公司_岳晓华","group":"supervisoryCommittee","name":"岳晓华","title":"监事","isMale":false,"age":"49","degree":"硕士","salary":"0.00","stockAmount":"-","description":"岳晓华:女,1971年12月出生,中国注册会计师、注册资产评估师、注册税务师。岳女士持有位于中国北京市的中央财政金融学院(现中央财经大学)经济学学士学位及位于中国北京市的中央财经大学管理科学与工程学院授予的经济学硕士学位。岳女士曾就职于德勤华永会计师事务所,2003年加入华润(集团)有限公司,曾任中国华润总公司财务部高级经理,华润东阿阿胶有限公司财务总监,华润医药集团有限公司财务综合管理总监、财务管理部高级总监。现任华润医药集团有限公司财务管理部总经理、华润东阿阿胶有限公司董事、总经理。","lastUpdated":"2019-06-19"},{"id":"东阿阿胶股份有限公司_刘广立","group":"supervisoryCommittee","name":"刘广立","title":"职工监事","isMale":true,"age":"56","degree":"硕士","salary":"88.20万","stockAmount":"900","description":"刘广立,男,1964年7月出生,EMBA学历,东阿阿胶股份有限公司质量统计员、劳资管理员、销售人力资源部长、人力资源部长、总经理助理、人力资源总监、工会副主席等职务,现任东阿阿胶股份有限公司工会主席。","lastUpdated":"2018-06-27"},{"id":"东阿阿胶股份有限公司_冯东林","group":"supervisoryCommittee","name":"冯东林","title":"职工监事","isMale":false,"age":"53","degree":"硕士","salary":"89.70万","stockAmount":"-","description":"冯东林,女,1967年2月出生,毕业于山东医科大学中药专业,MBA学员,东阿阿胶股份有限公司二分厂厂长、质量部部长、办公室主任、企业管理部部长、战略管理部部长、制造部总监等职务,现任东阿阿胶股份有限公司销售运营部总经理。","lastUpdated":"2018-06-27"},{"id":"东阿阿胶股份有限公司_高登锋","group":"manager","name":"高登锋","title":"总裁","isMale":true,"age":"47","degree":"硕士","salary":"126.7万","stockAmount":"-","description":"高登锋,男,1973年1月出生,硕士研究生学历,工商管理硕士学位。1995年9月在东阿阿胶参加工作,历任东阿阿胶销售代表、销售主管、办事处经理、市场部经理/总监、西南西北区总监、高端产品事业部总监、江苏销售分公司总经理、苏皖销售分公司总经理、人力资源部总监、保健品公司总经理、电子商务公司总经理、助理总裁等职务。现任东阿阿胶股份有限公司党委委员、副总裁。","lastUpdated":"2020-05-27"},{"id":"东阿阿胶股份有限公司_吴怀峰","group":"manager","name":"吴怀峰","title":"董事会秘书","isMale":true,"age":"58","degree":"硕士","salary":"153.2万","stockAmount":"3.991万","description":"吴怀峰(曾用名:吴怀锋):男,1962年出生,会计师,1979年进入东阿阿胶厂工作,曾任财务科副科长、财务处长、山东东阿阿胶股份有限公司公司副总经理;参加过清华大学MBA培训,曾获山东省\"富民兴鲁\"劳动奖章,《新财富》第四届至第七届金牌董秘.现任山东东阿阿胶股份有限公司董事、副总经理董事会秘书。","lastUpdated":"2018-08-30"},{"id":"东阿阿胶股份有限公司_邓蓉","group":"manager","name":"邓蓉","title":"副总裁,财务总监","isMale":false,"age":"42","degree":"硕士","salary":"--","stockAmount":"-","description":"邓蓉,女,1978年9月出生,持有中南大学会计学学士和北京交通大学管理学硕士学位,曾任华润双鹤药业股份有限公司财务管理中心财务核算与税务管理部总经理、财务管理中心会计管理部总经理、华润双鹤财务管理中心总经理、财务共享服务中心总经理、会计管理总监、业务财务部总经理、财务职能部总经理等职务。现任华润双鹤药业股份有限公司财务管理中心总经理。","lastUpdated":"2020-04-01"},{"id":"东阿阿胶股份有限公司_王中诚","group":"manager","name":"王中诚","title":"副总裁","isMale":true,"age":"60","degree":"硕士","salary":"151.3万","stockAmount":"525","description":"王中诚:男,1960年9月出生,硕士研究生学历。毕业于山东省中医药学校中药专业,高级工程师,执业中药师。1982年进入东阿阿胶工作,历任质检科科长、质量处处长、副总经理。现任东阿阿胶股份有限公司副总裁。","lastUpdated":"2018-08-30"},{"id":"东阿阿胶股份有限公司_王延涛","group":"manager","name":"王延涛","title":"副总裁","isMale":true,"age":"47","degree":"硕士","salary":"128.7万","stockAmount":"-","description":"王延涛:男,1973年1月出生,硕士学位,主管中药师。1992年7月参加工作,东阿阿胶股份有限公司化验室化验员、质量管理部部长、党委办公室主任、总裁办副总经理、战略管理部总监、人力资源部总监、助理总裁。现任东阿阿胶股份有限公司助理总裁兼战略人资部总经理、党委副书记。","lastUpdated":"2018-08-30"},{"id":"东阿阿胶股份有限公司_任儒倬","group":"manager","name":"任儒倬","title":"副总裁","isMale":true,"age":"42","degree":"硕士","salary":"125.6万","stockAmount":"-","description":"任儒倬:男,1978年6月出生,本科学历,高级管理人员工商管理硕士学位。2000年7月参加工作,东阿阿胶股份有限公司战略发展部战略管理专员、办公室副总经理、战略投资部高级投资经理、战略规划与绩效部副总监、助理总裁。现任东阿阿胶股份有限公司助理总裁兼办公室总经理、党委委员。","lastUpdated":"2018-08-30"},{"id":"东阿阿胶股份有限公司_刘广源","group":"manager","name":"刘广源","title":"副总裁","isMale":true,"age":"45","degree":"本科","salary":"128.7万","stockAmount":"-","description":"刘广源:男,1975年8月出生,本科学历。1995年7月参加工作,东阿阿胶股份有限公司二分厂、保健品分厂工人、销售代表、市场督查专员、商务经理、OTC办事处副经理、OTC办事处经理、重庆分公司总经理、北京销售分公司总经理、山东分公司总经理、OTC华东大区总经理、助理总裁,东阿天龙食品有限公司总经理与原料拓展部部长。现任东阿阿胶股份有限公司助理总裁兼毛驴掌控部总经理、党委委员。","lastUpdated":"2018-08-30"},{"id":"东阿阿胶股份有限公司_李新华","group":"manager","name":"李新华","title":"副总裁","isMale":true,"age":"42","degree":"本科","salary":"130.5万","stockAmount":"-","description":"李新华:男,1978年5月出生,本科学历,学士学位。2002年7月参加工作,东阿阿胶股份有限公司杭州办事处台州实习代表、推广专员、南京办事处终端经理、办事处经理、北京办事处经理、OTC广东大区总经理、助理总裁兼广东大区总经理。现任东阿阿胶股份有限公司助理总裁兼OTC部总经理。","lastUpdated":"2018-08-30"},{"id":"东阿阿胶股份有限公司_李世忠","group":"manager","name":"李世忠","title":"副总裁","isMale":true,"age":"57","degree":"硕士","salary":"146.5万","stockAmount":"-","description":"李世忠:男,1963年出生,持有中欧国际工商学院高级管理人员工商管理专业硕士学位。曾任东阿阿胶股份有限公司销售经理、实验室主任、研究所所长,新疆和田阿华阿胶有限公司董事长、山东聊城阿华制药有限公司董事长、山东阿华包装印务有限公司董事长、东阿阿胶阿华医疗器械有限公司董事长,华润东阿阿胶有限公司常务副总经理,东阿阿胶股份有限公司副总裁。现任东阿阿胶股份有限公司党委委员、纪委书记。","lastUpdated":"2018-10-30"}],"companyName":"东阿阿胶股份有限公司","province":"山东省","englishName":"Dong-E-E-Jiao Co Ltd","industry":"医药生物 — 中药Ⅱ","website":"www.dongeejiao.com","mainBusiness":"从事阿胶及阿胶系列产品的研发、生产和销售业务","productsName":["阿胶","复方阿胶浆","阿胶糕"],"actualController":"国务院国有资产监督管理委员会","actualControllerSharePercentage":"11.65%","registeredCapital":"6.54亿元","employeeAmount":"4952","phone":"86-0635-3264069","location":"山东省聊城市东阿县阿胶街78号","chineseDescription":"山东东阿阿胶股份有限公司主营业务为从事阿胶及阿胶系列产品的研发、生产和销售业务。公司主要产品有阿胶、复方阿胶浆、阿胶糕、“真颜”品牌系列。公司获得“中国药品品牌榜价值排行榜榜首”、“改革开放40年山东40强品牌”、全国品牌故事大奖赛总决赛一等奖，第十一次入围“中国500最具价值品牌”等荣誉。截止2019年度，公司先后获得山东省科技进步奖一等奖3项、中国专利奖优秀奖3项、中国专利奖1项。","foundedDate":"1993-05-28","goPublicDate":"1996-07-29","companyHistory":"","shareholders":[{"organizationId":"00208287","holderName":"华润东阿阿胶有限公司","totalShare":"1.51亿","sharePercentage":"23.14%"},{"organizationId":"T000077094","holderName":"华润医药投资有限公司","totalShare":"5793.51万","sharePercentage":"8.86%"},{"organizationId":"T000125370","holderName":"香港中央结算有限公司","totalShare":"3541.34万","sharePercentage":"5.41%"},{"organizationId":"T000059585","holderName":"前海人寿保险股份有限公司-自有资金","totalShare":"2202.73万","sharePercentage":"3.37%"},{"organizationId":"T000073058","holderName":"中国证券金融股份有限公司","totalShare":"1955.59万","sharePercentage":"2.99%"},{"organizationId":"","holderName":"中国农业银行股份有限公司-易方达消费行业股票型证券投资基金","totalShare":"1113.70万","sharePercentage":"1.70%"},{"organizationId":"T000280241","holderName":"中央汇金资产管理有限责任公司","totalShare":"933.96万","sharePercentage":"1.43%"},{"organizationId":"","holderName":"中国太平洋人寿保险股份有限公司-分红-个人分红","totalShare":"738.17万","sharePercentage":"1.13%"},{"organizationId":"","holderName":"MERRILLLYNCHINTERNATIONAL","totalShare":"715.32万","sharePercentage":"1.09%"},{"organizationId":"","holderName":"东阿阿胶股份有限公司回购专用证券账户","totalShare":"617.42万","sharePercentage":"0.94%"}],"englishDescription":"Dong-E-E-Jiao Co., Ltd., formerly SHAN DONG DONG-E E-JIAO CO., LTD, is a China-based company principally engaged in the research, development, production and sale of traditional Chinese medicines of Ejiao and Ejiao series products. The Company distributes its Ejiao and Ejiao series products under the brand name of Dong-E E-Jiao. The Company is also involved in the production and sale of medical instrument and pharmaceutical excipients, as well as pharmaceutical trading business. The Company operates its business in domestic market, with East China and South China as its main markets.","englishIndustry":"Biotechnology & Drugs","Price to earnings (ttm)":"--","Price to sales (ttm)":"12.65","Price to book (mrq)":"2.73","Price to cash flow (ttm)":"--","Total debt to equity (mrq)":"2.13","Lt debt to equity (mrq)":"0.00","Return on investment (ttm)":"-8.52","Return on equity (ttm)":"-7.43","Income statement":{"Revenue":"2,958.62","Total revenue":"2,958.62","Cost of revenue, total":"1,549.20","Gross profit":"1,409.43","Selling/general/admin. expenses, total":"1,709.05","Research & development":"186.24","Depreciation/amortization":"83.63","Interest exp.(inc.),net-operating, total":"(35.61)","Unusual expense (income)":"4.01","Other operating expenses, total":"(20.82)","Total operating expense":"3,475.70","Operating income":"(517.07)","Other, net":"11.87","Net income before taxes":"(505.21)","Provision for income taxes":"(59.82)","Net income after taxes":"(445.38)","Minority interest":"1.47","Net income before extra. items":"(443.92)","Net income":"(443.92)","Income available to com excl extraord":"(443.92)","Income available to com incl extraord":"(443.92)","Diluted net income":"(443.92)","Diluted weighted average shares":"654.02","Diluted eps excluding extraord items":"(0.68)","Dps - common stock primary issue":"0.20","Diluted normalized eps":"(0.67)","Gain (loss) on sale of assets":"(9.48)"},"Balance sheet":{"Cash":"0.05","Cash & equivalents":"1,922.09","Short term investments":"633.79","Cash and short term investments":"2,555.93","Accounts receivable - trade, net":"1,263.01","Total receivables, net":"2,024.07","Total inventory":"3,521.67","Prepaid expenses":"92.54","Other current assets, total":"0.00","Total current assets":"8,194.20","Property/plant/equipment, total - gross":"2,951.73","Accumulated depreciation, total":"(602.76)","Property/plant/equipment, total - net":"2,348.97","Goodwill, net":"0.91","Intangibles, net":"433.13","Long term investments":"371.67","Other long term assets, total":"304.78","Total assets":"11,653.67","Accounts payable":"287.61","Accrued expenses":"127.12","Notes payable/short term debt":"312.27","Other current liabilities, total":"847.09","Total current liabilities":"1,574.10","Total long term debt":"0.00","Total debt":"312.27","Deferred income tax":"0.44","Minority interest":"48.14","Other liabilities, total":"56.07","Total liabilities":"1,678.75","Common stock, total":"654.02","Additional paid-in capital":"690.58","Retained earnings (accumulated deficit)":"8,858.10","Treasury stock - common":"(227.52)","Other equity, total":"(0.26)","Total equity":"9,974.93","Total liabilities & shareholders' equity":"11,653.67","Total common shares outstanding":"654.02","Tangible book value per share, common eq":"14.59","Long term debt":"0.00"},"Cash flow":{"Cash receipts":"3,450.52","Cash payments":"(1,891.27)","Cash taxes paid":"(937.32)","Changes in working capital":"(1,741.92)","Cash from operating activities":"(1,119.99)","Capital expenditures":"(336.13)","Other investing cash flow items, total":"2,172.69","Cash from investing activities":"1,836.56","Financing cash flow items":"(207.97)","Total cash dividends paid":"(715.34)","Issuance (retirement) of debt, net":"(7.00)","Cash from financing activities":"(930.31)","Foreign exchange effects":"(0.01)","Net change in cash":"(213.75)"},"keyMetrics":{"Price and Volume":{"Price closing or last bid":"40.72","52 Week High":"41.34","52 Week Low":"24.92","Pricing date":"","10 Day Average Trading Volume":"12.34","Market Capitalization":"26,631.76","52 Week High Date":"","52 Week Low Date":"","3 Month Average Trading Volume":"189.13","Beta":"0.79","1 Day Price Change":"-0.29","13 Week Price Return (Daily)":"31.35","26 Week Price Return (Daily)":"19.31","5 Day Price Return (Daily)":"17.96","52 Week Price Return (Daily)":"24.15","Year To Date Price Return (Daily)":"15.13","Month to Date Price Return (Daily)":"13.71","Price Relative to S&P500 (4 Week)":"5.85","Price Relative to S&P500 (13 Week)":"3.27","Price Relative to S&P500 (26 Week)":"-6.55","Price Relative to S&P500 (52 Week)":"-15.63","Price Relative to S&P500 (YTD)":"-11.95"},"Per Share Data":{"EPS excl. Extra Items (Annual)":"-0.68","EPS excl. Extra Items (TTM)":"-1.56","EPS Normalized (Annual)":"-0.67","Revenue per Share (Annual)":"4.52","Revenue per Share (TTM)":"3.51","Book Value (Per Share Annual)":"15.25","Book Value (Per Share Quarterly)":"14.94","Tangible Book Value (Per Share Annual)":"14.59","Tangible Book Value (Per Share Quarterly)":"14.28","Cash Per Share (Per Share Annual)":"3.91","Cash Per Share (Per Share Quarterly)":"4.00","Cash Flow (Per Share Annual)":"-0.48","Cash Flow (Per Share TTM)":"--","Dividend (Per Share Annual)":"0.20","Dividends (Per Share TTM)":"0.20","EBITD (Per Share TTM)":"-1.80","EPS Basic excl. Extra Items (Annual)":"-0.68","EPS Basic excl. Extra Items (TTM)":"-1.56","EPS incl. Extra Items (Annual)":"-0.68","EPS incl. Extra Items (TTM)":"-1.56","Free Cash Flow (Per Share TTM)":"-2.18","Dividend (Per Share 5Y)":"0.76"},"Valuation":{"P/E excl. Extra Items (Annual)":"--","P/E excl. Extra Items (TTM)":"--","P/E Normalized (Annual)":"--","Price to sales (Annual)":"9.00","Price to sales (TTM)":"12.65","Price to Tangible Book (Annual)":"2.79","Price to Tangible Book (Quarterly)":"2.85","Price to Free Cash Flow (Per Share Annual)":"--","Price to Cash Flow (Per Share TTM)":"--","Price to Free Cash Flow (Per Share TTM)":"--","Price to Book (Annual)":"2.67","Price to Book (Quarterly)":"2.73","P/E Basic excl. Extra Items (TTM)":"--","P/E excl. Extra Items High (TTM)":"24.42","P/E excl. Extra Items Low (TTM)":"12.41","P/E incl. Extra Items (TTM)":"--","Net Debt (Interim)":"-2,406.69","Net Debt (Annual)":"-2,243.66","Dividend Yield (5Y)":"1.58","Dividend Yield":"0.50","Current Dividend Yield (TTM)":"0.50"},"Financial Strength":{"Free Cash Flow (Annual)":"-2,171.46","Current Ratio (Annual)":"5.21","Net Interest coverage (Annual)":"--","Long Term Debt/Equity (Annual)":"0.00","Payout Ratio (Annual)":"--","Quick Ratio (Annual)":"2.97","Total Debt/Total Equity (Annual)":"3.13","Current EV/Free Cash Flow (Annual)":"--","Current EV/Free Cash Flow (TTM)":"--","Current Ratio (Quarterly)":"6.23","Long Term Debt/Equity (Quarterly)":"0.00","Quick Ratio (Quarterly)":"3.46","Total Debt/Total Equity (Quarterly)":"2.13","Free Cash Flow (TTM)":"-1,306.96","Net Interest Coverage (TTM)":"--","Payout Ratio (TTM)":"--"},"Margins":{"Gross Margin (Annual)":"47.64","Gross Margin (TTM)":"31.69","Net Profit Margin % (Annual)":"-15.05","Net Profit Margin (TTM)":"-43.69","Operating Margin (Annual)":"-17.48","Operating Margin (TTM)":"-51.35","Pretax Margin (TTM)":"-50.73","Pretax Margin (Annual)":"-17.08","Operating Margin (5Y)":"28.58","Pretax Margin (5Y)":"28.77","Free Operating Cash Flow/Revenue (5Y)":"-4.37","Free Operating Cash Flow/Revenue (TTM)":"-62.10","Gross Margin (5Y)":"63.81","Net Profit Margin (5Y)":"24.39"},"Management Effectiveness":{"Return on Assets (Annual)":"-3.49","Return on Equity (TTM)":"-7.43","Return on Average Equity (Annual)":"-4.17","Return on Average equity (TTM)":"-8.58","Return on Investment (Annual)":"-4.16","Return on Investment (TTM)":"-8.52","Return on Average Assets (5Y)":"13.20","Return on Average Equity (5Y)":"16.11","Return on Investment (5Y)":"16.02","Asset Turnover (Annual)":"0.23","Asset Turnover (TTM)":"0.17","Inventory Turnover (Annual)":"0.45","Inventory Turnover (TTM)":"0.43","Net Income/Employee (Annual)":"-91,006.23","Net Income/Employee (TTM)":"-185,688.80","Receivables Turnover (Annual)":"2.73","Receivables Turnover (TTM)":"1.60","Revenue/Employee (Annual)":"604,540.80","Revenue/Employee (TTM)":"424,995.20"},"Growth":{"Revenue Growth (Quarterly YoY)":"-66.11","Revenue Growth Rate (5Y)":"-5.90","EPS Growth (Quarterly YoY)":"-121.33","EPS Growth (TTM YoY)":"-154.60","EPS Growth Rate (5Y)":"--","Dividend Growth Rate (3Y)":"-39.12","Revenue Growth (TTM YoY)":"-69.65","Revenue Growth (Per Share 5Y)":"-5.90","Revenue Growth Rate (3Y)":"-22.34","EPS Growth Rate (3Y)":"--","Book Value Growth Rate (Per Share 5Y)":"10.99","Tangible Book Value Total Equity CAGR (5Y)":"10.90","Capital Spending growth rate 5 year":"4.04","EBITDA CAGR (5Y)":"--","EBITDA Interim CAGR (5Y)":"--","Free Operating Cash Flow CAGR (5Y)":"--","Total Debt CAGR (5Y)":"--","Net Profit Margin Growth Rate (5Y)":"--"},"Income Statement":{"Revenue (Annual)":"2,958.62","Revenue (TTM)":"2,104.58","EBITD (Annual)":"-415.51","EBITD (TTM)":"-1,081.87","Earnings Before Taxes (Annual)":"-505.21","Earnings Before Taxes (TTM)":"-1,067.64","Net Income to Common (Annual)":"-443.92","Net Income to Common (TTM)":"-920.96","Earnings Before Taxes Normalized (Annual)":"-501.20","Net Income Available to Common Normalized (Annual)":"-441.31","Diluted Normalized EPS excl. Extra Items (TTM)":"-1.56"}}}